CRGX - CARGO Therapeutics, Inc.
4.47
-0.070 -1.566%
Share volume: 10,919,722
Last Updated: 08-18-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$4.54
-0.07
-0.02%
Summary score
33%
Profitability
35%
Dept financing
21%
Liquidity
50%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-13.34%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
13.74%
Debt ratio change over timeo
0%
Current Ratio
14.55%
Quick Ratio
0%
Cash Position Ratio
3.29%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-14.26%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
14.27%
Debt ratio change over timeo
0%
Current Ratio
14%
Quick Ratio
0%
Cash Position Ratio
3.22%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-24.43%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
21.96%
Debt ratio change over time
0%
Current Ratio
6.3%
Quick Ratio
0%
Cash Position Ratio
1.2%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CRGX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 18.97% | 6.3% | 4.9% |
| Return on assets | -13.34% | 3.05% | 3.04% | 2.27% |
| Return on sales | 0% | 29.08% | 27.81% | 22.73% |
| Return on invested capital | 0% | 5.17% | 3.5% | 4.81% |
| Profitability | 0% | 100% | 74% | 68% |
| Total debt ratio | 13.74% | 92.73% | 66.91% | 46.96% |
| Debt ratio change over time | 0% | 21.88% | 144.36% | 14.72% |
| Dept financing | 4% | 29% | 43% | 15% |
| Current Ratio | 14% | 1.25% | 1.34% | 1.58% |
| Quick Ratio | 0% | 0.92% | 1.18% | 1.05% |
| Cash Position Ratio | 3.22% | 0.44% | 0.54% | 0.46% |
| Liquididy | 50% | 30% | 24% | 34% |
| Short-term ratios | CRGX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -14.26% | 2.68% | 3.48% | 1.89% |
| Return on sales | 0% | 21.68% | 28.93% | 21.33% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 38% | 50% | 32% |
| Total debt ratio | 14.27% | 92.96% | 66.32% | 40.7% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 29% | 25% | 18% | 11% |
| Current Ratio | 14% | 1.25% | 1.34% | 1.58% |
| Quick Ratio | 0% | 0.92% | 1.18% | 1.05% |
| Cash Position Ratio | 3.22% | 0.44% | 0.54% | 0.46% |
| Liquididy | 50% | 25% | 32% | 29% |